Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onat Kadioglu

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|April 22, 2014
The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein--a well-known, yet poorly understood drug transporterMaen Zeino, Mohamed E M Saeed, Onat Kadioglu, et al.
Archives of Toxicology|February 27, 2015
Synthetic cajanin stilbene acid derivatives inhibit c-MYC in breast cancer cellsOnat Kadioglu, Yujie Fu, Benjamin Wiench, et al.
Investigational New Drugs|February 1, 2015
Aptamers as a novel tool for diagnostics and therapyOnat Kadioglu, Anna Helena Malczyk, Henry Johannes Greten, et al.
Archives of Toxicology|May 22, 2021
Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validationOnat Kadioglu, Sabine M Klauck, Edmond Fleischer, et al.
Frontiers in Pharmacology|May 2, 2018
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by <i>in Silico</i> and <i>in Vitro</i> AnalysesOnat Kadioglu, Mohamed Saeed, Victor Kuete, et al.
Scientific Reports|November 9, 2016
Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistanceOnat Kadioglu, Jingming Cao, Nadezda Kosyakova, et al.
Anticancer Research|May 13, 2015
Kaempferol Is an Anti-Inflammatory Compound with Activity towards NF-κB Pathway ProteinsOnat Kadioglu, Janine Nass, Mohamed E M Saeed, et al.
Targeted Oncology|November 21, 2014
Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicalsOnat Kadioglu, Jingming Cao, Mohamed E M Saeed, et al.
Cells|January 30, 2020
Identification of Novel Rare <i>ABCC1</i> Transporter Mutations in Tumor Biopsies of Cancer PatientsOnat Kadioglu, Mohamed Saeed, Markus Munder, et al.
Biochemical Pharmacology|January 26, 2016
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analysesOnat Kadioglu, Mohamed E M Saeed, Massimo Valoti, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|April 22, 2014
The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein--a well-known, yet poorly understood drug transporterMaen Zeino, Mohamed E M Saeed, Onat Kadioglu, et al.
Archives of Toxicology|February 27, 2015
Synthetic cajanin stilbene acid derivatives inhibit c-MYC in breast cancer cellsOnat Kadioglu, Yujie Fu, Benjamin Wiench, et al.
Investigational New Drugs|February 1, 2015
Aptamers as a novel tool for diagnostics and therapyOnat Kadioglu, Anna Helena Malczyk, Henry Johannes Greten, et al.
Archives of Toxicology|May 22, 2021
Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validationOnat Kadioglu, Sabine M Klauck, Edmond Fleischer, et al.
Frontiers in Pharmacology|May 2, 2018
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by <i>in Silico</i> and <i>in Vitro</i> AnalysesOnat Kadioglu, Mohamed Saeed, Victor Kuete, et al.
Scientific Reports|November 9, 2016
Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistanceOnat Kadioglu, Jingming Cao, Nadezda Kosyakova, et al.
Anticancer Research|May 13, 2015
Kaempferol Is an Anti-Inflammatory Compound with Activity towards NF-κB Pathway ProteinsOnat Kadioglu, Janine Nass, Mohamed E M Saeed, et al.
Targeted Oncology|November 21, 2014
Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicalsOnat Kadioglu, Jingming Cao, Mohamed E M Saeed, et al.
Cells|January 30, 2020
Identification of Novel Rare <i>ABCC1</i> Transporter Mutations in Tumor Biopsies of Cancer PatientsOnat Kadioglu, Mohamed Saeed, Markus Munder, et al.
Biochemical Pharmacology|January 26, 2016
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analysesOnat Kadioglu, Mohamed E M Saeed, Massimo Valoti, et al.
Pageof 6